Airway Administration of Budesonide Combined With Pulmonary Surfactant to Prevent Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta‐Analysis
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Kaixu Wang, Chen Dan, Shuqiang Gao, Yue Guang, Rong Ju |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Effectiveness of Intratracheal Surfactant Mixed With Budesonide for Prevention of Bronchopulmonary Dysplasia
par: Adnan S. Ahmad, et autres
Publié: (2025)
par: Adnan S. Ahmad, et autres
Publié: (2025)
Azithromycin for Preventing Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Cohort Study
par: Yali Zeng, et autres
Publié: (2024)
par: Yali Zeng, et autres
Publié: (2024)
Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia
par: Melissa House, et autres
Publié: (2025)
par: Melissa House, et autres
Publié: (2025)
Dynamic Risk‐Stratification Models for Bronchopulmonary Dysplasia in Extremely Preterm Very Low Birth Weight Infants
par: Ting Zhao, et autres
Publié: (2025)
par: Ting Zhao, et autres
Publié: (2025)
Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants
par: Genichiro Sotodate, et autres
Publié: (2025)
par: Genichiro Sotodate, et autres
Publié: (2025)
Predischarge Betamethasone in Infants Diagnosed With Bronchopulmonary Dysplasia
par: Tal‐El Ernest, et autres
Publié: (2025)
par: Tal‐El Ernest, et autres
Publié: (2025)
Comment on “Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants”
par: Yi‐Li Hung, et autres
Publié: (2026)
par: Yi‐Li Hung, et autres
Publié: (2026)
The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension
par: Stephanie M. Tsoi, et autres
Publié: (2026)
par: Stephanie M. Tsoi, et autres
Publié: (2026)
Social Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia
par: Haley Urbach, et autres
Publié: (2025)
par: Haley Urbach, et autres
Publié: (2025)
Noninvasive Neurally Adjusted Ventilatory Assist for the Management of Severe Tracheobronchomalacia in a Preterm Infant With Bronchopulmonary Dysplasia: A Case Report
par: Dina W. Abdulghani, et autres
Publié: (2026)
par: Dina W. Abdulghani, et autres
Publié: (2026)
Bronchopulmonary Dysplasia Definitions As Predictors of Early Childhood Pulmonary Function
par: Brianna C. Aoyama, et autres
Publié: (2025)
par: Brianna C. Aoyama, et autres
Publié: (2025)
Exercise Capacity and Ventilatory Response in Children Who Were Born Preterm, With and Without Bronchopulmonary Dysplasia
par: Eleana Kouroukli, et autres
Publié: (2026)
par: Eleana Kouroukli, et autres
Publié: (2026)
Associations of Community Material Neighborhood Deprivation With the Diagnosis of Asthma Among Infants With Bronchopulmonary Dysplasia (BPD)
par: Jonathan J. Szeto, et autres
Publié: (2026)
par: Jonathan J. Szeto, et autres
Publié: (2026)
Current Practices for Bronchopulmonary Dysplasia‐Associated Pulmonary Hypertension in Neonates: A Survey Study in Spain
par: Macarena García‐Gozalo, et autres
Publié: (2025)
par: Macarena García‐Gozalo, et autres
Publié: (2025)
A Novel and Promising Method for Prediction of Early Surfactant Requirement in Preterm Infants With Respiratory Distress Syndrome: Pulmonary Near‐Infrared Spectroscopy
par: Meliha Aksoy, et autres
Publié: (2025)
par: Meliha Aksoy, et autres
Publié: (2025)
Increased Mean Airway Pressure Is Associated With Successful Transition to a Portable Home Ventilator in Patients With Grade 3 Bronchopulmonary Dysplasia
par: Robin L McKinney, et autres
Publié: (2025)
par: Robin L McKinney, et autres
Publié: (2025)
Lung Ultrasound and Lung Clearance Index After Preterm Birth: A Structure‐Function Framework for Bronchopulmonary Dysplasia and Post‐Prematurity Respiratory Disease
par: Jan Neneman, et autres
Publié: (2026)
par: Jan Neneman, et autres
Publié: (2026)
Common Severity‐Based Definitions of Bronchopulmonary Dysplasia Are not Associated With Outpatient Morbidities
par: Robin L. McKinney, et autres
Publié: (2025)
par: Robin L. McKinney, et autres
Publié: (2025)
Nasal High‐Flow Therapy Versus Low‐Flow Oxygen Therapy Post‐Discharge in Infants With Bronchopulmonary Dysplasia: A Retrospective Observational Study
par: Alessia Mariani, et autres
Publié: (2024)
par: Alessia Mariani, et autres
Publié: (2024)
Bronchopulmonary Dysplasia in the First Year: Insights Into Severity, Medication Use, and Healthcare Utilization
par: Eliaz Brumer, et autres
Publié: (2025)
par: Eliaz Brumer, et autres
Publié: (2025)
Predictors of Bronchodilator Response on Oscillometry and Spirometry in School‐Age Children With Bronchopulmonary Dysplasia
par: Julia. X. Lee, et autres
Publié: (2025)
par: Julia. X. Lee, et autres
Publié: (2025)
Urine Metabolomics to Predict Bronchopulmonary Dysplasia: A Single‐Center Prospective Study
par: Lauren Strauch, et autres
Publié: (2026)
par: Lauren Strauch, et autres
Publié: (2026)
Caregiver Social Needs and Outpatient Respiratory Outcomes in a Cohort of Children With Bronchopulmonary Dysplasia
par: Danielle Carlin, et autres
Publié: (2025)
par: Danielle Carlin, et autres
Publié: (2025)
Outpatient Medication Prescribing Patterns in Bronchopulmonary Dysplasia: A Survey of Clinical Practices and Challenges
par: Michael C. Tracy, et autres
Publié: (2026)
par: Michael C. Tracy, et autres
Publié: (2026)
Lower Respiratory Tract Bacterial Profiles Are Associated With Respiratory Severity and Bronchopulmonary Dysplasia in Neonates
par: Jelte Kelchtermans, et autres
Publié: (2025)
par: Jelte Kelchtermans, et autres
Publié: (2025)
Identification and Validation of TFF3 as a Diagnostic Biomarker and Therapeutic Agent for Bronchopulmonary Dysplasia
par: Zhenzhuang Zou, et autres
Publié: (2025)
par: Zhenzhuang Zou, et autres
Publié: (2025)
Using Positive End‐Expiratory Pressure to Predict and Quantify Tracheobronchomalacia in Grade 3 Bronchopulmonary Dysplasia
par: Stephanie A. Adaikalam, et autres
Publié: (2025)
par: Stephanie A. Adaikalam, et autres
Publié: (2025)
Flow‐Driver‐Generated Synchronized Nasal Intermittent Positive‐Pressure Ventilation Versus Biphasic Positive Airway Pressure After Extubation in Preterm Infants
par: Toshihiko Suzuki, et autres
Publié: (2025)
par: Toshihiko Suzuki, et autres
Publié: (2025)
Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in ≥ 35 Weeks Gestational Age Infants
par: Etze Chotzoglou, et autres
Publié: (2025)
par: Etze Chotzoglou, et autres
Publié: (2025)
Modifiable and Non‐Modifiable Risk Factors for Tracheostomy in Preterm Infants
par: Brandon Dudeck, et autres
Publié: (2025)
par: Brandon Dudeck, et autres
Publié: (2025)
The Reference Interval for the Attainment of Comparable Term Functional Levels of Pulmonary Oxygenation Capacity in Healthy Preterm Infants: A Single‐Center Retrospective Study
par: Masako Yasui, et autres
Publié: (2025)
par: Masako Yasui, et autres
Publié: (2025)
Airway Anomalies Predict Risk of Pediatric Pulmonary Hypertension
par: Elana R. Kriegel, et autres
Publié: (2025)
par: Elana R. Kriegel, et autres
Publié: (2025)
HHHFNC Versus NIPPV Delivered by Long Narrow Cannula in Preterm Infants: Randomized Noninferiority Trial
par: Ayala Gover, et autres
Publié: (2025)
par: Ayala Gover, et autres
Publié: (2025)
Lung Ultrasound Score as a Predictor for Extubation Failure in Preterm Infants
par: Wegdan Mawlana, et autres
Publié: (2025)
par: Wegdan Mawlana, et autres
Publié: (2025)
Measuring the Effects of Furosemide on Lung Mechanics Using Oscillometry in Preterm Infants
par: Colm P. Travers, et autres
Publié: (2026)
par: Colm P. Travers, et autres
Publié: (2026)
Interactions of Patent Ductus Arteriosus and Ventilation on Preterm Pulmonary Vascular Disease
par: Christopher W. Myers, et autres
Publié: (2025)
par: Christopher W. Myers, et autres
Publié: (2025)
Antenatal Late Preterm Infants Exposure to Steroids (ALPINES) and Risk of Respiratory Distress and Hypoglycemia: A Retrospective Chart Review
par: Naveed Ur Rehman Durrani, et autres
Publié: (2025)
par: Naveed Ur Rehman Durrani, et autres
Publié: (2025)
Commentary on: Comparison of Bovine Lipid Extract Surfactant and Poractant Alfa Administered via LISA in Preterm Infants (28 + 0 to 34 + 6 Week) With Respiratory Distress Syndrome: A Randomized Controlled Trial
par: Brigitte Lemyre, et autres
Publié: (2025)
par: Brigitte Lemyre, et autres
Publié: (2025)
Uncovering the Physiologic Basis of Improved Oxygenation during Prone Positioning in Preterm Infants
par: R. Sindelar, et autres
Publié: (2025)
par: R. Sindelar, et autres
Publié: (2025)
Investigations for Bronchiolitis in Infants: An Overview of Reviews and Systematic Review of Primary Studies
par: Kate Loveys, et autres
Publié: (2026)
par: Kate Loveys, et autres
Publié: (2026)
Documents similaires
-
Effectiveness of Intratracheal Surfactant Mixed With Budesonide for Prevention of Bronchopulmonary Dysplasia
par: Adnan S. Ahmad, et autres
Publié: (2025) -
Azithromycin for Preventing Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Cohort Study
par: Yali Zeng, et autres
Publié: (2024) -
Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia
par: Melissa House, et autres
Publié: (2025) -
Dynamic Risk‐Stratification Models for Bronchopulmonary Dysplasia in Extremely Preterm Very Low Birth Weight Infants
par: Ting Zhao, et autres
Publié: (2025) -
Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants
par: Genichiro Sotodate, et autres
Publié: (2025)